GS, Y., JS, D., LM, F., J, L., ZP, T., L, D., . . . JH, W. (2025). Development and validation of hierarchical signature for precision individualized therapy based on the landscape associated with necroptosis in clear cell renal cell carcinoma. Frontiers in pharmacology, 16, 1470145. https://doi.org/10.3389/fphar.2025.1470145
Chicago Style (17th ed.) CitationGS, Yao, Dai JS, Fu LM, Lin J, Tan ZP, Dai L, Chen W, Luo JH, and Wei JH. "Development and Validation of Hierarchical Signature for Precision Individualized Therapy Based on the Landscape Associated with Necroptosis in Clear Cell Renal Cell Carcinoma." Frontiers in Pharmacology 16 (2025): 1470145. https://doi.org/10.3389/fphar.2025.1470145.
MLA (9th ed.) CitationGS, Yao, et al. "Development and Validation of Hierarchical Signature for Precision Individualized Therapy Based on the Landscape Associated with Necroptosis in Clear Cell Renal Cell Carcinoma." Frontiers in Pharmacology, vol. 16, 2025, p. 1470145, https://doi.org/10.3389/fphar.2025.1470145.
